相关实验视频

Updated: Jan 11, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

在复发性或耐火性多发性骨髓瘤中优化melflufen (melphalan flufenamide) 的使用:临床实践建议

Heinz Ludwig¹, Elias K Mai², Marion Högner³

¹Wilhelminen Cancer Research Institute, c/o Department of Medicine I, Center for Oncology, Hematology with Day Clinic and Palliative Care, Clinic Ottakring, Vienna, Austria. heinz.ludwig@extern.gesundheitsverbund.at.

Annals of hematology

|November 9, 2025

概括

梅尔弗鲁芬 (梅尔法兰胺) 在复发性或耐火性多发性骨髓瘤 (RRMM) 中提供持续反应. 专家提供有关其使用,管理副作用和选择患者的指导,特别是那些具有高风险因素的患者.

科学领域:

血液学血液学血液学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

多发性骨髓瘤 (MM) 是一种血液性恶性瘤.
复发性或耐药性多发性髓瘤 (RRMM) 存在重大治疗挑战.
梅尔弗鲁芬 (梅尔法兰胺) 是一种新型的类药物联合体.

研究的目的:

评估梅尔芬在治疗RRMM患者中的作用.
提供有关梅尔芬的专家建议和患者选择.
概述与梅尔芬治疗相关的不良事件管理策略.

主要方法:

专家小组对现有的临床试验数据进行了审查.
在RRMM中分析melflufen的疗效和安全性.
基于证据的临床实践建议的制定.

主要成果:

梅尔夫卢芬在临床试验中表现出持续和持久的反应.
推的初始剂量为40毫克静脉注射,每28天服用甲甲.
副作用主要是可管理的血液毒性和感染.

结论:

梅尔弗鲁芬是RRMM患者的可行的治疗选择,包括那些患有高风险遗传突变的患者.
没有先前高剂量梅尔法兰或长时间无治疗间隔的患者应考虑.
专家指导支持在特定RRMM患者群体中最佳使用梅尔芬.

关键词:

梅尔弗鲁芬是什么意思梅尔法兰芬胺是什么意思多发性骨髓瘤是一种多发性骨髓瘤.复发或耐火性复发或耐火性复发

更多相关视频

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...